TRANSCODE THERAPEUTICS INC (RNAZ)
US89357L3033 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -14.93M | -18.55M | -17.57M | -6.84M | -2.34M | |||
| Depreciation Amortization | 112.25K | 123.50K | 98.60K | 42.50K | N/A | |||
| Change In Working Capital | -3.32M | -1.08M | 1.34M | 401.90K | 309.80K | |||
| Interest Paid | 29.03K | 32.90K | 37.10K | 17.90K | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other non cash items | 2.28M | 1.43M | 364.80K | 1.13M | 1.54M | |||
| OPERATING CASH FLOW | -15.85M | -18.07M | -15.76M | -5.27M | -493.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -21.26K | -35.60K | -100.90K | -254.80K | N/A | |||
| Other Investing Activity | N/A | N/A | 0.00 | 3.00K | N/A | |||
| INVESTING CASH FLOW | -21.26K | -35.60K | -100.90K | -251.80K | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 1.19M | |||
| Stock Issued/Repurchased | 10.30M | 15.91M | 6.00K | 26.35M | N/A | |||
| Other Financing Activity | N/A | N/A | 0.00 | -831.70K | -73.50K | |||
| FINANCING CASH FLOW | 10.30M | 15.91M | 6.00K | 25.52M | 1.12M | |||
| CHANGE IN CASH | -5.58M | -2.20M | -15.86M | 20.00M | 623.60K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -15.85M | -18.07M | -15.76M | -5.27M | -493.00K | |||
| Capital Expenditure | -21.26K | -35.60K | -100.90K | -254.80K | N/A | |||
| FREE CASH FLOW | -15.87M | -18.11M | -15.86M | -5.52M | -493.00K | |||
All data in USD